Correspondence

Joint letter from the CMA and the General Pharmaceutical Council: pricing during the COVID-19 pandemic

An open letter to pharmacy owners and superintendent pharmacists.

From:
Competition and Markets Authority
Published
29 June 2020

Documents

Joint letter from the CMA and the General Pharmaceutical Council: pricing during the COVID-19 pandemic

PDF, 106 KB, 3 pages

Details

Read all of our updates about coronavirus (COVID-19), and how the CMA is responding to the ongoing outbreak on our dedicated COVID-19 response page.

Published 29 June 2020

Related content